Page last updated: 2024-08-24

raxofelast and Diabetes Mellitus, Type 2

raxofelast has been researched along with Diabetes Mellitus, Type 2 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anggård, EE; Brett, SE; Chowienczyk, PJ; Gopaul, NK; Marchetti, M; Meeking, D; Ritter, JM; Russell-Jones, DL	1

Trials

1 trial(s) available for raxofelast and Diabetes Mellitus, Type 2

Article	Year
Oral treatment with an antioxidant (raxofelast) reduces oxidative stress and improves endothelial function in men with type II diabetes. Diabetologia, 2000, Volume: 43, Issue:8 Topics: Acetylcholine; Administration, Oral; Antioxidants; Benzofurans; Biomarkers; Brachial Artery; Diabetes Mellitus, Type 2; Dinoprost; Endothelium, Vascular; Female; Forearm; Gas Chromatography-Mass Spectrometry; Humans; Male; Middle Aged; Nitric Oxide Donors; Nitroprusside; Oxidative Stress; Reference Values; Vasodilation; Vitamin E	2000

Article

Year

Oral treatment with an antioxidant (raxofelast) reduces oxidative stress and improves endothelial function in men with type II diabetes.

Diabetologia, 2000, Volume: 43, Issue:8

Topics: Acetylcholine; Administration, Oral; Antioxidants; Benzofurans; Biomarkers; Brachial Artery; Diabetes Mellitus, Type 2; Dinoprost; Endothelium, Vascular; Female; Forearm; Gas Chromatography-Mass Spectrometry; Humans; Male; Middle Aged; Nitric Oxide Donors; Nitroprusside; Oxidative Stress; Reference Values; Vasodilation; Vitamin E

2000